| Overall | Micropapillary | Papillary | Pseudoglandular | Solid | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | No | Yes | P | No | Yes | P | No | Yes | P | No | Yes | P | |
N | 79 | 30 | 49 | Â | 19 | 60 | Â | 19 | 60 | Â | 23 | 56 | Â |
Age at diagnosis, mean (SD) | 61.4 (11.1) | 61.3 (9.1) | 61.4 (12.2) | 0.97 | 62.2 (7.4) | 61.1 (12.1) | 0.64 | 60.9 (11.3) | 61.5 (11.1) | 0.84 | 63.1 (13.0) | 60.7 (10.3) | 0.38 |
Stage, n (%) | |||||||||||||
 I,II | 8 (10) | 8 (27) | 0 (0) | 0.0002 | 2 (11) | 6 (10) | 0.33 | 2 (11) | 6 (10) | 0.33 | 2 (9) | 6 (11) | 0.32 |
 III,IV | 71 (90) | 22 (73) | 49 (100) |  | 17 (89) | 54 (90) |  | 17 (89) | 54 (90) |  | 21 (91) | 50 (89) |  |
Debulking status, n (%) | |||||||||||||
 Suboptimal | 18 (24) | 4 (14) | 14 (30) | 0.07 | 4 (21) | 14 (25) | 0.24 | 3 (17) | 15 (26) | 0.19 | 7 (32) | 11 (20) | 0.29 |
 Optimal | 58 (76) | 25 (86) | 33 (70) |  | 15 (79) | 43 (75) |  | 15 (83) | 43 (74) |  | 15 (68) | 43 (80) |  |
Lymphovascular Invasion, n (%) | |||||||||||||
 Yes | 62 (79) | 15 (50) | 47 (96) | <.0001 | 16 (84.2) | 46 (77) | 0.21 | 14 (74) | 48 (80) | 0.20 | 17 (74) | 45 (80) | 0.53 |
 No | 17 (21) | 15 (50) | 2 (4) |  | 3 (16) | 14 (23) |  | 5 (26) | 12 (20) |  | 6 (26) | 11 (20) |  |
Cystic Component, n (%) | |||||||||||||
 Yes | 54 (69) | 20 (67) | 34 (7) | 0.70 | 9 (50) | 45 (75) | 0.04 | 14 (78) | 40 (67) | 0.16 | 16 (7) | 38 (68) | 0.68 |
 No | 24 (30) | 10 (33) | 14 (29) |  | 9 (50) | 15 (25) |  | 4 (22) | 20 (33) |  | 6 (27) | 18 (32) |  |
STIC, n (%) | |||||||||||||
 Yes | 20 (25) | 6 (23) | 14 (31) | 0.47 | 2 (12) | 18 (33) | 0.06 | 1 (7) | 19 (34) | 0.03 | 9 (43) | 11 (22) | 0.08 |
 No | 51 (65) | 20 (77) | 31 (69) |  | 15 (88) | 36 (67) |  | 14 (93) | 37 (66) |  | 12 (57) | 39 (78) |  |
TIL, n (%) | |||||||||||||
 Yes | 32 (41) | 13 (43) | 19 (40) | 0.74 | 10 (56) | 22 (37) | 0.15 | 6 (33) | 26 (43) | 0.45 | 7 (32) | 25 (45) | 0.30 |
 No | 46 (58) | 17 (57) | 29 (60) |  | 8 (44) | 38 (63) |  | 12 (67) | 34 (57) |  | 15 (68) | 31 (55) |  |
Response to therapy | |||||||||||||
 Sensitive | 59 (76) | 24 (83) | 35 (71) | 0.26 | 15 (79) | 44 (75) | 0.70 | 15 (79) | 44 (75) | 0.7 | 18 (78) | 41 (75) | 0.73 |
 Resistant | 19 (24) | 5 (17) | 14 (29) |  | 4 (21) | 15 (25) |  | 4 (21) | 15 (25) |  | 5 (22) | 14 (25) |  |
Vital Status, n (%) | |||||||||||||
 Alive | 24 (30) | 15 (50) | 9 (18) | 0.003 | 9 (47) | 15 (25) | 0.06 | 5 (26) | 19 (32) | 0.66 | 6 (26) | 18 (32) | 0.59 |
 Dead | 55 (70) | 15 (50) | 40 (82) |  | 10 (53) | 45 (75) |  | 14 (74) | 41 (68) |  | 17 (74) | 38 (68) |  |